{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:11:06Z","timestamp":1793373066637,"version":"4.5.0"},"reference-count":118,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T00:00:00Z","timestamp":1677715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>A newly identified form of cell death known as ferroptosis is characterized by the peroxidation of lipids in response to iron. Rapid progress in research on ferroptosis in glioma and neuroblastoma has promoted the exploitation of ferroptosis in related therapy. This manuscript provides a review of the findings on ferroptosis-related therapy in glioblastoma and neuroblastoma and outlines the mechanisms involved in ferroptosis in glioma and neuroblastoma. We summarize some recent data on traditional drugs, natural compounds and nanomedicines used as ferroptosis inducers in glioma and neuroblastoma, as well as some bioinformatic analyses of genes involved in ferroptosis. Moreover, we summarize some data on the associations of ferroptosis with the tumor immunotherapy and TMZ drug resistance. Finally, we discuss future directions for ferroptosis research in glioma and neuroblastoma and currently unresolved issues.<\/jats:p>","DOI":"10.3389\/fonc.2023.1065994","type":"journal-article","created":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T10:48:46Z","timestamp":1677840526000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["Opportunities and challenges related to ferroptosis in glioma and neuroblastoma"],"prefix":"10.3389","volume":"13","author":[{"given":"Huizhong","family":"Chi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingtong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijie","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3322\/caac.21693","article-title":"Brain and other central nervous system tumor statistics, 2021","volume":"71","author":"Miller","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"iii1","DOI":"10.1093\/neuonc\/noab200","article-title":"CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the united states in 2014-2018","volume":"23","author":"Ostrom","year":"2021","journal-title":"Neuro Oncol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3322\/caac.21613","article-title":"Management of glioblastoma: State of the art and future directions","volume":"70","author":"Tan","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"B4","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3322\/caac.21613","article-title":"Management of glioblastoma: State of the art and future directions","volume":"70","author":"Tan","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03539-7","article-title":"DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer","volume":"593","author":"Mao","year":"2021","journal-title":"Nature"},{"key":"B6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41392-020-00428-9","article-title":"Ferroptosis: mechanisms and links with diseases","volume":"6","author":"Yan","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B7","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13045-019-0720-y","article-title":"Ferroptosis, a new form of cell death: opportunities and challenges in cancer","volume":"12","author":"Mou","year":"2019","journal-title":"J Hematol Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.956361","article-title":"Ferroptosis in sepsis: The mechanism, the role and the therapeutic potential","volume":"13","author":"Lei","year":"2022","journal-title":"Front Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2021.166287","article-title":"NMN recruits GSH to enhance GPX4-mediated ferroptosis defense in UV irradiation induced skin injury","volume":"1868","author":"Feng","year":"2022","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1705-2","article-title":"The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis","volume":"575","author":"Bersuker","year":"2019","journal-title":"Nature"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1707-0","article-title":"FSP1 is a glutathione-independent ferroptosis suppressor","volume":"575","author":"Doll","year":"2019","journal-title":"Nature"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20120097","article-title":"Dihydro-orotate dehydrogenase is physically associated with the respiratory complex and its loss leads to mitochondrial dysfunction","volume":"33","author":"Fang","year":"2013","journal-title":"Biosci Rep"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1080\/21655979.2021.2011633","article-title":"The ubiquitin hydrolase OTUB1 promotes glioma cell stemness via suppressing ferroptosis through stabilizing SLC7A11 protein","volume":"12","author":"Zhao","year":"2021","journal-title":"Bioengineered"},{"key":"B14","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41419-022-04524-2","article-title":"RNA binding protein NKAP protects glioblastoma cells from ferroptosis by promoting SLC7A11 mRNA splicing in an m6A-dependent manner","volume":"13","author":"Sun","year":"2022","journal-title":"Cell Death Dis"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2019.08.096","article-title":"RSL3 induced autophagic death in glioma cells via causing glycolysis dysfunction","volume":"518","author":"Wang","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2022.02.103","article-title":"The RNA-binding protein fragile-x mental retardation autosomal 1 (FXR1) modulates glioma cells sensitivity to temozolomide by regulating ferroptosis","volume":"603","author":"Wei","year":"2022","journal-title":"Biochem Biophys Res Commun"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.101703","article-title":"Expression of gamma-glutamyltransferase 1 in glioblastoma cells confers resistance to cystine deprivation-induced ferroptosis","volume":"298","author":"Hayashima","year":"2022","journal-title":"J Biol Chem"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.841418","article-title":"Glioblastoma relapses show increased markers of vulnerability to ferroptosis","volume":"12","author":"Kram","year":"2022","journal-title":"Front Oncol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/s41418-022-00943-y","article-title":"p53 in ferroptosis regulation: the new weapon for the old guardian","volume":"29","author":"Liu","year":"2022","journal-title":"Cell Death Differ"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-042320-025840","article-title":"A balancing act: p53 activity from tumor suppression to pathology and therapeutic implications","volume":"17","author":"Wang","year":"2022","journal-title":"Annu Rev Pathol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13578-022-00764-z","article-title":"The dual role of p62 in ferroptosis of glioblastoma according to p53 status","volume":"12","author":"Yuan","year":"2022","journal-title":"Cell Biosci"},{"key":"B22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13578-022-00791-w","article-title":"Rho family GTPase 1 (RND1), a novel regulator of p53, enhances ferroptosis in glioblastoma","volume":"12","author":"Sun","year":"2022","journal-title":"Cell Biosci"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1607152113","article-title":"Activation of SAT1 engages polyamine metabolism with p53-mediated ferroptotic responses","volume":"113","author":"Ou","year":"2016","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B24","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.molcel.2015.06.011","article-title":"Glutaminolysis and transferrin regulate ferroptosis","volume":"59","author":"Gao","year":"2015","journal-title":"Mol Cell"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-019-0305-6","article-title":"ALOX12 is required for p53-mediated tumour suppression through a distinct ferroptosis pathway","volume":"21","author":"Chu","year":"2019","journal-title":"Nat Cell Biol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/nature17157","article-title":"Deletions linked to TP53 loss drive cancer through p53-independent mechanisms","volume":"531","author":"Liu","year":"2016","journal-title":"Nature"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M114.616359","article-title":"p53 protein-mediated regulation of phosphoglycerate dehydrogenase (PHGDH) is crucial for the apoptotic response upon serine starvation","volume":"290","author":"Ou","year":"2015","journal-title":"J Biol Chem"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1101\/gad.334219.119","article-title":"MDM2 and MDMX promote ferroptosis by PPAR\u03b1-mediated lipid remodeling","volume":"34","author":"Venkatesh","year":"2020","journal-title":"Genes Dev"},{"key":"B29","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.semcancer.2021.03.010","article-title":"The complexity of p53-mediated metabolic regulation in tumor suppression","volume":"85","author":"Liu","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.949863","article-title":"ACSL4 as a potential target and biomarker for anticancer: From molecular mechanisms to clinical therapeutics","volume":"13","author":"Hou","year":"2022","journal-title":"Front Pharmacol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3892\/or.2019.7419","article-title":"ACSL4 suppresses glioma cells proliferation via activating ferroptosis","volume":"43","author":"Cheng","year":"2020","journal-title":"Oncol Rep"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1080\/10715762.2021.1962009","article-title":"MicroRNA-670-3p suppresses ferroptosis of human glioblastoma cells through targeting ACSL4","volume":"55","author":"Bao","year":"2021","journal-title":"Free Radic Res"},{"key":"B33","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/s41419-022-04997-1","article-title":"Hsp90 induces Acsl4-dependent glioma ferroptosis via dephosphorylating Ser637 at Drp1","volume":"13","author":"Miao","year":"2022","journal-title":"Cell Death Dis"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.802124","article-title":"GPX7 is targeted by miR-29b and GPX7 knockdown enhances ferroptosis induced by erastin in glioma","volume":"11","author":"Zhou","year":"2022","journal-title":"Front Oncol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1021\/acscentsci.9b01063","article-title":"GTP cyclohydrolase 1\/Tetrahydrobiopterin counteract ferroptosis through lipid remodeling","volume":"6","author":"Kraft","year":"2020","journal-title":"ACS Cent Sci"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-020-01622-3","article-title":"Loss of COPZ1 induces NCOA4 mediated autophagy and ferroptosis in glioblastoma cell lines","volume":"40","author":"Zhang","year":"2021","journal-title":"Oncogene"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.834595","article-title":"Matrix remodeling-associated protein 8 as a novel indicator contributing to glioma immune response by regulating ferroptosis","volume":"13","author":"Xu","year":"2022","journal-title":"Front Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41419-022-05044-9","article-title":"High levels of NRF2 sensitize temozolomide-resistant glioblastoma cells to ferroptosis via ABCC1\/MRP1 upregulation","volume":"13","author":"de Souza","year":"2022","journal-title":"Cell Death Dis"},{"key":"B39","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.jconrel.2022.08.024","article-title":"Polymeric and small molecule-conjugates of temozolomide as improved therapeutic agents for glioblastoma multiforme","volume":"350","author":"Jatyan","year":"2022","journal-title":"J Control Release"},{"key":"B40","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1186\/s13046-019-1413-7","article-title":"Dihydroartemisinin-induced unfolded protein response feedback attenuates ferroptosis via PERK\/ATF4\/HSPA5 pathway in glioma cells","volume":"38","author":"Chen","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-021-00700-w","article-title":"ATF3 contributes to brucine-triggered glioma cell ferroptosis via promotion of hydrogen peroxide and iron","volume":"42","author":"Lu","year":"2021","journal-title":"Acta Pharmacol Sin"},{"key":"B42","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.canlet.2018.04.021","article-title":"Pseudolaric acid b triggers ferroptosis in glioma cells via activation of Nox4 and inhibition of xCT","volume":"428","author":"Wang","year":"2018","journal-title":"Cancer Lett"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117425","article-title":"Amentoflavone suppresses cell proliferation and induces cell death through triggering autophagy-dependent ferroptosis in human glioma","volume":"247","author":"Chen","year":"2020","journal-title":"Life Sci"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/2915019","article-title":"RSL3 drives ferroptosis through NF-\u03baB pathway activation and GPX4 depletion in glioblastoma","volume":"2021","author":"Li","year":"2021","journal-title":"Oxid Med Cell Longev"},{"key":"B45","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3892\/ol.2020.11980","article-title":"Dihydrotanshinone i inhibits human glioma cell proliferation via the activation of ferroptosis","volume":"20","author":"Tan","year":"2020","journal-title":"Oncol Lett"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/9925919","article-title":"Apatinib induces ferroptosis of glioma cells through modulation of the VEGFR2\/Nrf2 pathway","volume":"2022","author":"Xia","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.859621","article-title":"Sevoflurane induces ferroptosis of glioma cells through activating the ATF4-CHAC1 pathway","volume":"12","author":"Xu","year":"2022","journal-title":"Front Oncol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-022-01800-y","article-title":"Targeting NQO1\/GPX4-mediated ferroptosis by plumbagin suppresses in vitro and in vivo glioma growth","volume":"127","author":"Zhan","year":"2022","journal-title":"Br J Cancer"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2019.101413","article-title":"AR ubiquitination induced by the curcumin analog suppresses growth of temozolomide-resistant glioblastoma through disrupting GPX4-mediated redox homeostasis","volume":"30","author":"Chen","year":"2020","journal-title":"Redox Biol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s11011-022-00983-w","article-title":"Capsaicin induces redox imbalance and ferroptosis through ACSL4\/GPx4 signaling pathways in U87-MG and U251 glioblastoma cells","volume":"38","author":"Hacioglu","year":"2023","journal-title":"Metab Brain Dis"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1002\/tox.23662","article-title":"The dual role of boron in vitro neurotoxication of glioblastoma cells via SEMA3F\/NRP2 and ferroptosis signaling pathways","volume":"38","author":"Kar","year":"2023","journal-title":"Environ Toxicol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.0c12042","article-title":"Glioblastoma therapy using codelivery of cisplatin and glutathione peroxidase targeting siRNA from iron oxide nanoparticles","volume":"12","author":"Zhang","year":"2020","journal-title":"ACS Appl Mater Interfaces"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1039\/d2bm00562j","article-title":"Synergistic therapy for orthotopic gliomas via biomimetic nanosonosensitizer-mediated sonodynamic therapy and ferroptosis","volume":"10","author":"Zhu","year":"2022","journal-title":"Biomater Sci"},{"key":"B54","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s12951-022-01360-6","article-title":"Biomimetic GBM-targeted drug delivery system boosting ferroptosis for immunotherapy of orthotopic drug-resistant GBM","volume":"20","author":"Liu","year":"2022","journal-title":"J Nanobiotechnology"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.121163","article-title":"Versatile metal-phenolic network nanoparticles for multitargeted combination therapy and magnetic resonance tracing in glioblastoma","volume":"278","author":"Zhang","year":"2021","journal-title":"Biomaterials"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202105451","article-title":"Synchronous disintegration of ferroptosis defense axis via engineered exosome-conjugated magnetic nanoparticles for glioblastoma therapy","volume":"9","author":"Li","year":"2022","journal-title":"Adv Sci (Weinh)"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00897","article-title":"A potential mechanism of temozolomide resistance in glioma-ferroptosis","volume":"10","author":"Hu","year":"2020","journal-title":"Front Oncol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/s41419-018-0864-7","article-title":"Inhibition of autophagy increases susceptibility of glioblastoma stem cells to temozolomide by igniting ferroptosis","volume":"9","author":"Buccarelli","year":"2018","journal-title":"Cell Death Dis"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-022-02736-3","article-title":"LINC01564 promotes the TMZ resistance of glioma cells by upregulating NFE2L2 expression to inhibit ferroptosis","volume":"59","author":"Luo","year":"2022","journal-title":"Mol Neurobiol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14091762","article-title":"Immunogenic cell death enhances immunotherapy of diffuse intrinsic pontine glioma: From preclinical to clinical studies","volume":"14","author":"Liu","year":"2022","journal-title":"Pharmaceutics"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0792-9","article-title":"Neoantigen vaccine generates intratumoral t cell responses in phase ib glioblastoma trial","volume":"565","author":"Keskin","year":"2019","journal-title":"Nature"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2020.02.002","article-title":"Immunotherapy for glioma: Current management and future application","volume":"476","author":"Xu","year":"2020","journal-title":"Cancer Lett"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0349-y","article-title":"Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma","volume":"25","author":"Zhao","year":"2019","journal-title":"Nat Med"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxlet.2014.11.011","article-title":"Methionine and cystine double deprivation stress suppresses glioma proliferation via inducing ROS\/autophagy","volume":"232","author":"Liu","year":"2015","journal-title":"Toxicol Lett"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-20-2270","article-title":"Hypoxic glioma stem cell-derived exosomes containing Linc01060 promote progression of glioma by regulating the MZF1\/c-Myc\/HIF1\u03b1 axis","volume":"81","author":"Li","year":"2021","journal-title":"Cancer Res"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/now258","article-title":"Hypoxia in the glioblastoma microenvironment: shaping the phenotype of cancer stem-like cells","volume":"19","author":"Colwell","year":"2017","journal-title":"Neuro Oncol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-018-0003-5","article-title":"Current state of immunotherapy for glioblastoma","volume":"15","author":"Lim","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1038\/nn.4185","article-title":"The role of microglia and macrophages in glioma maintenance and progression","volume":"19","author":"Hambardzumyan","year":"2016","journal-title":"Nat Neurosci"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-021-00927-7","article-title":"Epigenetic encoding, heritability and plasticity of glioma transcriptional cell states","volume":"53","author":"Chaligne","year":"2021","journal-title":"Nat Genet"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290","article-title":"Diffuse glioma heterogeneity and its therapeutic implications","volume":"11","author":"Nicholson","year":"2021","journal-title":"Cancer Discovery"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drup.2015.02.002","article-title":"Overcoming the blood-brain tumor barrier for effective glioblastoma treatment","volume":"19","author":"van Tellingen","year":"2015","journal-title":"Drug Resist Update"},{"key":"B72","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.stem.2017.10.002","article-title":"Targeting glioma stem cell-derived pericytes disrupts the blood-tumor barrier and improves chemotherapeutic efficacy","volume":"21","author":"Zhou","year":"2017","journal-title":"Cell Stem Cell"},{"key":"B73","doi-asserted-by":"publisher","first-page":"4997","DOI":"10.1038\/s41467-020-18569-4","article-title":"Glioma-derived IL-33 orchestrates an inflammatory brain tumor microenvironment that accelerates glioma progression","volume":"11","author":"De Boeck","year":"2020","journal-title":"Nat Commun"},{"key":"B74","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ccell.2017.12.012","article-title":"Tumor evolution of glioma-intrinsic gene expression subtypes associates with immunological changes in the microenvironment","volume":"33","author":"Wang","year":"2018","journal-title":"Cancer Cell"},{"key":"B75","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/labinvest.2017.19","article-title":"Immune microenvironment of gliomas","volume":"97","author":"Gieryng","year":"2017","journal-title":"Lab Invest"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1215\/15228517-2007-010","article-title":"Inhibiting TGF-beta signaling restores immune surveillance in the SMA-560 glioma model","volume":"9","author":"Tran","year":"2007","journal-title":"Neuro Oncol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3390\/cells10020303","article-title":"Iron metabolism in the tumor microenvironment-implications for anti-cancer immune response","volume":"10","author":"Sacco","year":"2021","journal-title":"Cells"},{"key":"B78","doi-asserted-by":"publisher","first-page":"5424","DOI":"10.1038\/s41467-020-19193-y","article-title":"Neutrophil-induced ferroptosis promotes tumor necrosis in glioblastoma progression","volume":"11","author":"Yee","year":"2020","journal-title":"Nat Commun"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-20-0384","article-title":"Pharmacologic screening identifies metabolic vulnerabilities of CD8+ t cells","volume":"9","author":"Drijvers","year":"2021","journal-title":"Cancer Immunol Res"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/j.immuni.2021.05.003","article-title":"Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8+ t cells in tumors","volume":"54","author":"Xu","year":"2021","journal-title":"Immunity"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.cmet.2021.02.015","article-title":"CD36-mediated ferroptosis dampens intratumoral CD8+ t cell effector function and impairs their antitumor ability","volume":"33","author":"Ma","year":"2021","journal-title":"Cell Metab"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noac033","article-title":"Ferroptosis, as the most enriched programmed cell death process in glioma, induces immunosuppression and immunotherapy resistance","volume":"24","author":"Liu","year":"2022","journal-title":"Neuro Oncol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/s41419-022-05384-6","article-title":"Ferroptosis: a double-edged sword mediating immune tolerance of cancer","volume":"13","author":"Dang","year":"2022","journal-title":"Cell Death Dis"},{"key":"B84","doi-asserted-by":"publisher","first-page":"e001369","DOI":"10.1136\/jitc-2020-001369","article-title":"Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity","volume":"8","author":"Efimova","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N Engl J Med"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1412082","article-title":"Nivolumab in previously untreated melanoma without BRAF mutation","volume":"372","author":"Robert","year":"2015","journal-title":"N Engl J Med"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1302369","article-title":"Nivolumab plus ipilimumab in advanced melanoma","volume":"369","author":"Wolchok","year":"2013","journal-title":"N Engl J Med"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1172\/JCI139434","article-title":"TYRO3 induces anti-PD-1\/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis","volume":"131","author":"Jiang","year":"2021","journal-title":"J Clin Invest"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0433-y","article-title":"Mechanisms of immunotherapy resistance: lessons from glioblastoma","volume":"20","author":"Jackson","year":"2019","journal-title":"Nat Immunol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-2769","article-title":"Immunotherapy of primary brain tumors: Facts and hopes","volume":"24","author":"Buerki","year":"2018","journal-title":"Clin Cancer Res"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215945","article-title":"Neoantigen discovery and applications in glioblastoma: An immunotherapy perspective","volume":"550","author":"Wang","year":"2022","journal-title":"Cancer Lett"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-22-0750","article-title":"Intraventricular B7-H3 CAR t cells for diffuse intrinsic pontine glioma: Preliminary first-in-Human bioactivity and safety","volume":"13","author":"Vitanza","year":"2023","journal-title":"Cancer Discovery"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.590861","article-title":"Clinical and biological significances of a ferroptosis-related gene signature in glioma","volume":"10","author":"Zhuo","year":"2020","journal-title":"Front Oncol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1111\/cns.13654","article-title":"Ferroptosis-related gene signature predicts prognosis and immunotherapy in glioma","volume":"27","author":"Wan","year":"2021","journal-title":"CNS Neurosci Ther"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20211640","article-title":"Ferroptosis-related gene signature correlates with the tumor immune features and predicts the prognosis of glioma patients","volume":"41","author":"Hu","year":"2021","journal-title":"Biosci Rep"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.747408","article-title":"Ferroptosis activation scoring model assists in chemotherapeutic agents' selection and mediates cross-talk with immunocytes in malignant glioblastoma","volume":"12","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.753680","article-title":"Prognostic model and nomogram construction based on a novel ferroptosis-related gene signature in lower-grade glioma","volume":"12","author":"Zhao","year":"2021","journal-title":"Front Genet"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/9107857","article-title":"A ferroptosis-related prognostic risk score model to predict clinical significance and immunogenic characteristics in glioblastoma multiforme","volume":"2021","author":"Xiao","year":"2021","journal-title":"Oxid Med Cell Longev"},{"key":"B99","doi-asserted-by":"publisher","first-page":"12854","DOI":"10.1038\/s41598-022-17308-7","article-title":"Remarkable immune and clinical value of novel ferroptosis-related genes in glioma","volume":"12","author":"Gao","year":"2022","journal-title":"Sci Rep"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/9408886","article-title":"Transcriptional patterns of lower-grade glioma patients with distinct ferroptosis levels, immunotherapy response, and temozolomide sensitivity","volume":"2022","author":"Tu","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.897702","article-title":"A novel prognostic signature based on glioma essential ferroptosis-related genes predicts clinical outcomes and indicates treatment in glioma","volume":"12","author":"Yun","year":"2022","journal-title":"Front Oncol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.880864","article-title":"Characterization of the ferroptosis-related genes for prognosis and immune infiltration in low-grade glioma","volume":"13","author":"Yan","year":"2022","journal-title":"Front Genet"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.861438","article-title":"Establishment and validation of a ferroptosis-related lncRNA signature for prognosis prediction in lower-grade glioma","volume":"13","author":"Huang","year":"2022","journal-title":"Front Neurol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12885-022-09313-w","article-title":"Abundant expression of ferroptosis-related SAT1 is related to unfavorable outcome and immune cell infiltration in low-grade glioma","volume":"22","author":"Mou","year":"2022","journal-title":"BMC Cancer"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.17305\/bjbms.2021.6888","article-title":"Identification and verification of the ferroptosis- and pyroptosis-associated prognostic signature for low-grade glioma","volume":"22","author":"Wang","year":"2022","journal-title":"Bosn J Basic Med Sci"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.16.6785","article-title":"The international neuroblastoma risk group (INRG) classification system: an INRG task force report","volume":"27","author":"Cohn","year":"2009","journal-title":"J Clin Oncol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1126\/science.aat6768","article-title":"A mechanistic classification of clinical phenotypes in neuroblastoma","volume":"362","author":"Ackermann","year":"2018","journal-title":"Science"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-20-1641","article-title":"MYCN-amplified neuroblastoma is addicted to iron and vulnerable to inhibition of the system xc-\/Glutathione axis","volume":"81","author":"Floros","year":"2021","journal-title":"Cancer Res"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1172\/JCI99032","article-title":"Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma","volume":"128","author":"Hassannia","year":"2018","journal-title":"J Clin Invest"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-022-00355-4","article-title":"MYCN mediates cysteine addiction and sensitizes neuroblastoma to ferroptosis","volume":"3","author":"Alborzinia","year":"2022","journal-title":"Nat Cancer"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14174113","article-title":"MYCN and metabolic reprogramming in neuroblastoma","volume":"14","author":"Bansal","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B112","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/s41419-021-03790-w","article-title":"MYCN mediates TFRC-dependent ferroptosis and reveals vulnerabilities in neuroblastoma","volume":"12","author":"Lu","year":"2021","journal-title":"Cell Death Dis"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_201806_15267","article-title":"Knockdown of ferroportin accelerates erastin-induced ferroptosis in neuroblastoma cells","volume":"22","author":"Geng","year":"2018","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2016.00308","article-title":"The protective role of mitochondrial ferritin on erastin-induced ferroptosis","volume":"8","author":"Wang","year":"2016","journal-title":"Front Aging Neurosci"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.774458","article-title":"CDC27-ODC1 axis promotes metastasis, accelerates ferroptosis and predicts poor prognosis in neuroblastoma","volume":"12","author":"Qiu","year":"2022","journal-title":"Front Oncol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0804577","article-title":"Recent advances in neuroblastoma","volume":"362","author":"Maris","year":"2010","journal-title":"N Engl J Med"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22168898","article-title":"A shortage of FTH induces ROS and sensitizes RAS-proficient neuroblastoma N2A cells to ferroptosis","volume":"22","author":"Lu","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.9b00814","article-title":"A new approach in cancer treatment: Discovery of Chlorido[N,N'-disalicylidene-1,2-phenylenediamine]iron(III) complexes as ferroptosis inducers","volume":"62","author":"Sagasser","year":"2019","journal-title":"J Med Chem"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1065994\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T10:48:51Z","timestamp":1677840531000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1065994\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,2]]},"references-count":118,"alternative-id":["10.3389\/fonc.2023.1065994"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2023.1065994","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,2]]},"article-number":"1065994"}}